Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Canagliflozin in Non-diabetic Overweight and Obesity Patients with Albuminuria
TCTR20190203003Recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in albuminuria, Overweight and obesity comparing Canagliflozin with Placebo (2 arms). Started Feb 2019; status: recruiting.
02
Drugs
canagliflozin
03
Conditions
albuminuriaOverweightobesity
Beyond the preview
Go deeper on TCTR20190203003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190203003.